Seref Bornovali, MD
Internal Medicine · Loveland, OHNPI 1508862244
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,250 of the $1,726 with a category attached, or 72.4%. Amgen accounts for 92.2% of it on its own, with 5 other manufacturers making up the rest.
Across 12 payments — averaging $143.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- Melinta Therapeutics, LLC$60
- Genentech, Inc.$26
- Astellas Pharma US Inc$18
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$16
- Vifor Pharma, Inc.$14
Across 154 payments — averaging $28,626 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$3.6M
- Vertex$288K
- Currax Pharmaceuticals LLC$252K
- Sanofi Pasteur Inc.$169K
- Biogen$60K
- Chugai Pharmaceutical Co., Ltd.$26K
- plus $26K from 4 others
What the payments were for
- Travel & lodging$1,25072%
- Food & beverage$47628%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 5 | $1,592 |
| Melinta Therapeutics, LLC | 3 | $60 |
| Genentech, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Vifor Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$1,427
How this compares
$1,726 in reported general payments places this provider in the 80th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $23,082 |
| Olanzapine | 18 | $1,706 |
| Potassium Chloride | 34 | $1,654 |
| Budesonide | 11 | $882 |
| Levetiracetam | 13 | $751 |
| Bupropion XlBupropion Hcl | 13 | $563 |
| Sertraline Hcl | 12 | $540 |
| Duloxetine Hcl | 14 | $511 |
| Atorvastatin Calcium | 21 | $501 |
| Gabapentin | 27 | $486 |
| Metoprolol Succinate | 14 | $296 |
| Nifedipine ErNifedipine | 12 | $283 |
| Famotidine | 14 | $276 |
| Allopurinol | 12 | $219 |
| Metoprolol Tartrate | 13 | $128 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Loveland
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
- Vincent MartinCincinnati$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.